Long non‐coding RNA‐MIR3142HG as a novel biomarker for assessing disease activity in children with Crohn's disease

Puntos clave

• The research aims to evaluate the effectiveness of lncRNA-MIR3142HG as a biomarker for assessing disease activity in pediatric Crohn's disease.
• Analyzed serum and intestinal mucosal levels of lncRNA-MIR3142HG
• Assessed the combined utility of lncRNA-MIR3142HG and fecal calprotectin
• Evaluated clinical and endoscopic activity in children
• Both serum and mucosal lncRNA-MIR3142HG were effective biomarkers
• Combined assessments with fecal calprotectin showed superior efficacy
• The findings suggest a promising tool for monitoring disease activity

Resumen